Global Saliva-based Screening Market Research Report 2024

Report ID: 1890722 | Published Date: Sep 2024 | No. of Page: 113 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Saliva-based Screening Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Direct Sample to PCR
        1.2.3 RT-qPCR
        1.2.4 Lateral Flow Assays
    1.3 Market by Application
        1.3.1 Global Saliva-based Screening Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Diagnostic Laboratories
        1.3.3 Hospitals & Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Saliva-based Screening Market Perspective (2017-2028)
    2.2 Saliva-based Screening Growth Trends by Region
        2.2.1 Saliva-based Screening Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Saliva-based Screening Historic Market Size by Region (2017-2022)
        2.2.3 Saliva-based Screening Forecasted Market Size by Region (2023-2028)
    2.3 Saliva-based Screening Market Dynamics
        2.3.1 Saliva-based Screening Industry Trends
        2.3.2 Saliva-based Screening Market Drivers
        2.3.3 Saliva-based Screening Market Challenges
        2.3.4 Saliva-based Screening Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Saliva-based Screening Players by Revenue
        3.1.1 Global Top Saliva-based Screening Players by Revenue (2017-2022)
        3.1.2 Global Saliva-based Screening Revenue Market Share by Players (2017-2022)
    3.2 Global Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Saliva-based Screening Revenue
    3.4 Global Saliva-based Screening Market Concentration Ratio
        3.4.1 Global Saliva-based Screening Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Saliva-based Screening Revenue in 2021
    3.5 Saliva-based Screening Key Players Head office and Area Served
    3.6 Key Players Saliva-based Screening Product Solution and Service
    3.7 Date of Enter into Saliva-based Screening Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Saliva-based Screening Breakdown Data by Type
    4.1 Global Saliva-based Screening Historic Market Size by Type (2017-2022)
    4.2 Global Saliva-based Screening Forecasted Market Size by Type (2023-2028)
5 Saliva-based Screening Breakdown Data by Application
    5.1 Global Saliva-based Screening Historic Market Size by Application (2017-2022)
    5.2 Global Saliva-based Screening Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Saliva-based Screening Market Size (2017-2028)
    6.2 North America Saliva-based Screening Market Size by Country (2017-2022)
    6.3 North America Saliva-based Screening Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Saliva-based Screening Market Size (2017-2028)
    7.2 Europe Saliva-based Screening Market Size by Country (2017-2022)
    7.3 Europe Saliva-based Screening Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Saliva-based Screening Market Size (2017-2028)
    8.2 Asia-Pacific Saliva-based Screening Market Size by Country (2017-2022)
    8.3 Asia-Pacific Saliva-based Screening Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Saliva-based Screening Market Size (2017-2028)
    9.2 Latin America Saliva-based Screening Market Size by Country (2017-2022)
    9.3 Latin America Saliva-based Screening Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Saliva-based Screening Market Size (2017-2028)
    10.2 Middle East & Africa Saliva-based Screening Market Size by Country (2017-2022)
    10.3 Middle East & Africa Saliva-based Screening Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Thermo Fisher scientific
        11.1.1 Thermo Fisher scientific Company Detail
        11.1.2 Thermo Fisher scientific Business Overview
        11.1.3 Thermo Fisher scientific Saliva-based Screening Introduction
        11.1.4 Thermo Fisher scientific Revenue in Saliva-based Screening Business (2017-2022)
        11.1.5 Thermo Fisher scientific Recent Development
    11.2 Qiagen
        11.2.1 Qiagen Company Detail
        11.2.2 Qiagen Business Overview
        11.2.3 Qiagen Saliva-based Screening Introduction
        11.2.4 Qiagen Revenue in Saliva-based Screening Business (2017-2022)
        11.2.5 Qiagen Recent Development
    11.3 Hologic
        11.3.1 Hologic Company Detail
        11.3.2 Hologic Business Overview
        11.3.3 Hologic Saliva-based Screening Introduction
        11.3.4 Hologic Revenue in Saliva-based Screening Business (2017-2022)
        11.3.5 Hologic Recent Development
    11.4 Takara Bio Inc
        11.4.1 Takara Bio Inc Company Detail
        11.4.2 Takara Bio Inc Business Overview
        11.4.3 Takara Bio Inc Saliva-based Screening Introduction
        11.4.4 Takara Bio Inc Revenue in Saliva-based Screening Business (2017-2022)
        11.4.5 Takara Bio Inc Recent Development
    11.5 Arcis Biotechnology Limited
        11.5.1 Arcis Biotechnology Limited Company Detail
        11.5.2 Arcis Biotechnology Limited Business Overview
        11.5.3 Arcis Biotechnology Limited Saliva-based Screening Introduction
        11.5.4 Arcis Biotechnology Limited Revenue in Saliva-based Screening Business (2017-2022)
        11.5.5 Arcis Biotechnology Limited Recent Development
    11.6 GeneProof
        11.6.1 GeneProof Company Detail
        11.6.2 GeneProof Business Overview
        11.6.3 GeneProof Saliva-based Screening Introduction
        11.6.4 GeneProof Revenue in Saliva-based Screening Business (2017-2022)
        11.6.5 GeneProof Recent Development
    11.7 Abacus ALS
        11.7.1 Abacus ALS Company Detail
        11.7.2 Abacus ALS Business Overview
        11.7.3 Abacus ALS Saliva-based Screening Introduction
        11.7.4 Abacus ALS Revenue in Saliva-based Screening Business (2017-2022)
        11.7.5 Abacus ALS Recent Development
    11.8 Chai Inc.
        11.8.1 Chai Inc. Company Detail
        11.8.2 Chai Inc. Business Overview
        11.8.3 Chai Inc. Saliva-based Screening Introduction
        11.8.4 Chai Inc. Revenue in Saliva-based Screening Business (2017-2022)
        11.8.5 Chai Inc. Recent Development
    11.9 Kolplast Group
        11.9.1 Kolplast Group Company Detail
        11.9.2 Kolplast Group Business Overview
        11.9.3 Kolplast Group Saliva-based Screening Introduction
        11.9.4 Kolplast Group Revenue in Saliva-based Screening Business (2017-2022)
        11.9.5 Kolplast Group Recent Development
    11.10 Lucence Health INc
        11.10.1 Lucence Health INc Company Detail
        11.10.2 Lucence Health INc Business Overview
        11.10.3 Lucence Health INc Saliva-based Screening Introduction
        11.10.4 Lucence Health INc Revenue in Saliva-based Screening Business (2017-2022)
        11.10.5 Lucence Health INc Recent Development
    11.11 Vitagene
        11.11.1 Vitagene Company Detail
        11.11.2 Vitagene Business Overview
        11.11.3 Vitagene Saliva-based Screening Introduction
        11.11.4 Vitagene Revenue in Saliva-based Screening Business (2017-2022)
        11.11.5 Vitagene Recent Development
    11.12 Therma Bright Inc
        11.12.1 Therma Bright Inc Company Detail
        11.12.2 Therma Bright Inc Business Overview
        11.12.3 Therma Bright Inc Saliva-based Screening Introduction
        11.12.4 Therma Bright Inc Revenue in Saliva-based Screening Business (2017-2022)
        11.12.5 Therma Bright Inc Recent Development
    11.13 ACON Laboratories, Inc
        11.13.1 ACON Laboratories, Inc Company Detail
        11.13.2 ACON Laboratories, Inc Business Overview
        11.13.3 ACON Laboratories, Inc Saliva-based Screening Introduction
        11.13.4 ACON Laboratories, Inc Revenue in Saliva-based Screening Business (2017-2022)
        11.13.5 ACON Laboratories, Inc Recent Development
    11.14 TODA PHARMA
        11.14.1 TODA PHARMA Company Detail
        11.14.2 TODA PHARMA Business Overview
        11.14.3 TODA PHARMA Saliva-based Screening Introduction
        11.14.4 TODA PHARMA Revenue in Saliva-based Screening Business (2017-2022)
        11.14.5 TODA PHARMA Recent Development
    11.15 Norgen Biotek Corp.
        11.15.1 Norgen Biotek Corp. Company Detail
        11.15.2 Norgen Biotek Corp. Business Overview
        11.15.3 Norgen Biotek Corp. Saliva-based Screening Introduction
        11.15.4 Norgen Biotek Corp. Revenue in Saliva-based Screening Business (2017-2022)
        11.15.5 Norgen Biotek Corp. Recent Development
    11.16 Assure Tech. (Hangzhou) Co., Ltd
        11.16.1 Assure Tech. (Hangzhou) Co., Ltd Company Detail
        11.16.2 Assure Tech. (Hangzhou) Co., Ltd Business Overview
        11.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Introduction
        11.16.4 Assure Tech. (Hangzhou) Co., Ltd Revenue in Saliva-based Screening Business (2017-2022)
        11.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Development
    11.17 Beijing Hotgen Biotech Co., Ltd
        11.17.1 Beijing Hotgen Biotech Co., Ltd Company Detail
        11.17.2 Beijing Hotgen Biotech Co., Ltd Business Overview
        11.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Introduction
        11.17.4 Beijing Hotgen Biotech Co., Ltd Revenue in Saliva-based Screening Business (2017-2022)
        11.17.5 Beijing Hotgen Biotech Co., Ltd Recent Development
    11.18 Nantong Diagnos Biotechnology Co., Ltd
        11.18.1 Nantong Diagnos Biotechnology Co., Ltd Company Detail
        11.18.2 Nantong Diagnos Biotechnology Co., Ltd Business Overview
        11.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Introduction
        11.18.4 Nantong Diagnos Biotechnology Co., Ltd Revenue in Saliva-based Screening Business (2017-2022)
        11.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Development
    11.19 NeuMoDx Molecular, Inc.
        11.19.1 NeuMoDx Molecular, Inc. Company Detail
        11.19.2 NeuMoDx Molecular, Inc. Business Overview
        11.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Introduction
        11.19.4 NeuMoDx Molecular, Inc. Revenue in Saliva-based Screening Business (2017-2022)
        11.19.5 NeuMoDx Molecular, Inc. Recent Development
    11.20 KYODO INTERNATIONAL INC.
        11.20.1 KYODO INTERNATIONAL INC. Company Detail
        11.20.2 KYODO INTERNATIONAL INC. Business Overview
        11.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Introduction
        11.20.4 KYODO INTERNATIONAL INC. Revenue in Saliva-based Screening Business (2017-2022)
        11.20.5 KYODO INTERNATIONAL INC. Recent Development
    11.21 Canvax
        11.21.1 Canvax Company Detail
        11.21.2 Canvax Business Overview
        11.21.3 Canvax Saliva-based Screening Introduction
        11.21.4 Canvax Revenue in Saliva-based Screening Business (2017-2022)
        11.21.5 Canvax Recent Development
    11.22 Zymo Research Corporation.
        11.22.1 Zymo Research Corporation. Company Detail
        11.22.2 Zymo Research Corporation. Business Overview
        11.22.3 Zymo Research Corporation. Saliva-based Screening Introduction
        11.22.4 Zymo Research Corporation. Revenue in Saliva-based Screening Business (2017-2022)
        11.22.5 Zymo Research Corporation. Recent Development
    11.23 Salimetrics
        11.23.1 Salimetrics Company Detail
        11.23.2 Salimetrics Business Overview
        11.23.3 Salimetrics Saliva-based Screening Introduction
        11.23.4 Salimetrics Revenue in Saliva-based Screening Business (2017-2022)
        11.23.5 Salimetrics Recent Development
    11.24 NEST Scientific USA
        11.24.1 NEST Scientific USA Company Detail
        11.24.2 NEST Scientific USA Business Overview
        11.24.3 NEST Scientific USA Saliva-based Screening Introduction
        11.24.4 NEST Scientific USA Revenue in Saliva-based Screening Business (2017-2022)
        11.24.5 NEST Scientific USA Recent Development
    11.25 Miraclean Technology Co. Ltd
        11.25.1 Miraclean Technology Co. Ltd Company Detail
        11.25.2 Miraclean Technology Co. Ltd Business Overview
        11.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Introduction
        11.25.4 Miraclean Technology Co. Ltd Revenue in Saliva-based Screening Business (2017-2022)
        11.25.5 Miraclean Technology Co. Ltd Recent Development
    11.26 Mawi DNA Technologies
        11.26.1 Mawi DNA Technologies Company Detail
        11.26.2 Mawi DNA Technologies Business Overview
        11.26.3 Mawi DNA Technologies Saliva-based Screening Introduction
        11.26.4 Mawi DNA Technologies Revenue in Saliva-based Screening Business (2017-2022)
        11.26.5 Mawi DNA Technologies Recent Development
    11.27 Cell Projects Ltd.
        11.27.1 Cell Projects Ltd. Company Detail
        11.27.2 Cell Projects Ltd. Business Overview
        11.27.3 Cell Projects Ltd. Saliva-based Screening Introduction
        11.27.4 Cell Projects Ltd. Revenue in Saliva-based Screening Business (2017-2022)
        11.27.5 Cell Projects Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Saliva-based Screening Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Direct Sample to PCR
    Table 3. Key Players of RT-qPCR
    Table 4. Key Players of Lateral Flow Assays
    Table 5. Global Saliva-based Screening Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Saliva-based Screening Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Saliva-based Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Saliva-based Screening Market Share by Region (2017-2022)
    Table 9. Global Saliva-based Screening Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Saliva-based Screening Market Share by Region (2023-2028)
    Table 11. Saliva-based Screening Market Trends
    Table 12. Saliva-based Screening Market Drivers
    Table 13. Saliva-based Screening Market Challenges
    Table 14. Saliva-based Screening Market Restraints
    Table 15. Global Saliva-based Screening Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Saliva-based Screening Market Share by Players (2017-2022)
    Table 17. Global Top Saliva-based Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saliva-based Screening as of 2021)
    Table 18. Ranking of Global Top Saliva-based Screening Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Saliva-based Screening Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Saliva-based Screening Product Solution and Service
    Table 22. Date of Enter into Saliva-based Screening Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Saliva-based Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Saliva-based Screening Revenue Market Share by Type (2017-2022)
    Table 26. Global Saliva-based Screening Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Saliva-based Screening Revenue Market Share by Type (2023-2028)
    Table 28. Global Saliva-based Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Saliva-based Screening Revenue Market Share by Application (2017-2022)
    Table 30. Global Saliva-based Screening Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Saliva-based Screening Revenue Market Share by Application (2023-2028)
    Table 32. North America Saliva-based Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Saliva-based Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Saliva-based Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Saliva-based Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Saliva-based Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Saliva-based Screening Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Saliva-based Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Saliva-based Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Saliva-based Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Saliva-based Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Thermo Fisher scientific Company Detail
    Table 43. Thermo Fisher scientific Business Overview
    Table 44. Thermo Fisher scientific Saliva-based Screening Product
    Table 45. Thermo Fisher scientific Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 46. Thermo Fisher scientific Recent Development
    Table 47. Qiagen Company Detail
    Table 48. Qiagen Business Overview
    Table 49. Qiagen Saliva-based Screening Product
    Table 50. Qiagen Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 51. Qiagen Recent Development
    Table 52. Hologic Company Detail
    Table 53. Hologic Business Overview
    Table 54. Hologic Saliva-based Screening Product
    Table 55. Hologic Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 56. Hologic Recent Development
    Table 57. Takara Bio Inc Company Detail
    Table 58. Takara Bio Inc Business Overview
    Table 59. Takara Bio Inc Saliva-based Screening Product
    Table 60. Takara Bio Inc Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 61. Takara Bio Inc Recent Development
    Table 62. Arcis Biotechnology Limited Company Detail
    Table 63. Arcis Biotechnology Limited Business Overview
    Table 64. Arcis Biotechnology Limited Saliva-based Screening Product
    Table 65. Arcis Biotechnology Limited Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 66. Arcis Biotechnology Limited Recent Development
    Table 67. GeneProof Company Detail
    Table 68. GeneProof Business Overview
    Table 69. GeneProof Saliva-based Screening Product
    Table 70. GeneProof Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 71. GeneProof Recent Development
    Table 72. Abacus ALS Company Detail
    Table 73. Abacus ALS Business Overview
    Table 74. Abacus ALS Saliva-based Screening Product
    Table 75. Abacus ALS Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 76. Abacus ALS Recent Development
    Table 77. Chai Inc. Company Detail
    Table 78. Chai Inc. Business Overview
    Table 79. Chai Inc. Saliva-based Screening Product
    Table 80. Chai Inc. Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 81. Chai Inc. Recent Development
    Table 82. Kolplast Group Company Detail
    Table 83. Kolplast Group Business Overview
    Table 84. Kolplast Group Saliva-based Screening Product
    Table 85. Kolplast Group Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 86. Kolplast Group Recent Development
    Table 87. Lucence Health INc Company Detail
    Table 88. Lucence Health INc Business Overview
    Table 89. Lucence Health INc Saliva-based Screening Product
    Table 90. Lucence Health INc Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 91. Lucence Health INc Recent Development
    Table 92. Vitagene Company Detail
    Table 93. Vitagene Business Overview
    Table 94. Vitagene Saliva-based ScreeningProduct
    Table 95. Vitagene Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 96. Vitagene Recent Development
    Table 97. Therma Bright Inc Company Detail
    Table 98. Therma Bright Inc Business Overview
    Table 99. Therma Bright Inc Saliva-based ScreeningProduct
    Table 100. Therma Bright Inc Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 101. Therma Bright Inc Recent Development
    Table 102. ACON Laboratories, Inc Company Detail
    Table 103. ACON Laboratories, Inc Business Overview
    Table 104. ACON Laboratories, Inc Saliva-based ScreeningProduct
    Table 105. ACON Laboratories, Inc Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 106. ACON Laboratories, Inc Recent Development
    Table 107. TODA PHARMA Company Detail
    Table 108. TODA PHARMA Business Overview
    Table 109. TODA PHARMA Saliva-based ScreeningProduct
    Table 110. TODA PHARMA Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 111. TODA PHARMA Recent Development
    Table 112. Norgen Biotek Corp. Company Detail
    Table 113. Norgen Biotek Corp. Business Overview
    Table 114. Norgen Biotek Corp. Saliva-based ScreeningProduct
    Table 115. Norgen Biotek Corp. Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 116. Norgen Biotek Corp. Recent Development
    Table 117. Assure Tech. (Hangzhou) Co., Ltd Company Detail
    Table 118. Assure Tech. (Hangzhou) Co., Ltd Business Overview
    Table 119. Assure Tech. (Hangzhou) Co., Ltd Saliva-based ScreeningProduct
    Table 120. Assure Tech. (Hangzhou) Co., Ltd Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 121. Assure Tech. (Hangzhou) Co., Ltd Recent Development
    Table 122. Beijing Hotgen Biotech Co., Ltd Company Detail
    Table 123. Beijing Hotgen Biotech Co., Ltd Business Overview
    Table 124. Beijing Hotgen Biotech Co., Ltd Saliva-based ScreeningProduct
    Table 125. Beijing Hotgen Biotech Co., Ltd Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 126. Beijing Hotgen Biotech Co., Ltd Recent Development
    Table 127. Nantong Diagnos Biotechnology Co., Ltd Company Detail
    Table 128. Nantong Diagnos Biotechnology Co., Ltd Business Overview
    Table 129. Nantong Diagnos Biotechnology Co., Ltd Saliva-based ScreeningProduct
    Table 130. Nantong Diagnos Biotechnology Co., Ltd Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 131. Nantong Diagnos Biotechnology Co., Ltd Recent Development
    Table 132. NeuMoDx Molecular, Inc. Company Detail
    Table 133. NeuMoDx Molecular, Inc. Business Overview
    Table 134. NeuMoDx Molecular, Inc. Saliva-based ScreeningProduct
    Table 135. NeuMoDx Molecular, Inc. Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 136. NeuMoDx Molecular, Inc. Recent Development
    Table 137. KYODO INTERNATIONAL INC. Company Detail
    Table 138. KYODO INTERNATIONAL INC. Business Overview
    Table 139. KYODO INTERNATIONAL INC. Saliva-based ScreeningProduct
    Table 140. KYODO INTERNATIONAL INC. Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 141. KYODO INTERNATIONAL INC. Recent Development
    Table 142. Canvax Company Detail
    Table 143. Canvax Business Overview
    Table 144. Canvax Saliva-based ScreeningProduct
    Table 145. Canvax Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 146. Canvax Recent Development
    Table 147. Zymo Research Corporation. Company Detail
    Table 148. Zymo Research Corporation. Business Overview
    Table 149. Zymo Research Corporation. Saliva-based ScreeningProduct
    Table 150. Zymo Research Corporation. Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 151. Zymo Research Corporation. Recent Development
    Table 152. Salimetrics Company Detail
    Table 153. Salimetrics Business Overview
    Table 154. Salimetrics Saliva-based ScreeningProduct
    Table 155. Salimetrics Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 156. Salimetrics Recent Development
    Table 157. NEST Scientific USA Company Detail
    Table 158. NEST Scientific USA Business Overview
    Table 159. NEST Scientific USA Saliva-based ScreeningProduct
    Table 160. NEST Scientific USA Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 161. NEST Scientific USA Recent Development
    Table 162. Miraclean Technology Co. Ltd Company Detail
    Table 163. Miraclean Technology Co. Ltd Business Overview
    Table 164. Miraclean Technology Co. Ltd Saliva-based ScreeningProduct
    Table 165. Miraclean Technology Co. Ltd Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 166. Miraclean Technology Co. Ltd Recent Development
    Table 167. Mawi DNA Technologies Company Detail
    Table 168. Mawi DNA Technologies Business Overview
    Table 169. Mawi DNA Technologies Saliva-based ScreeningProduct
    Table 170. Mawi DNA Technologies Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 171. Mawi DNA Technologies Recent Development
    Table 172. Cell Projects Ltd. Company Detail
    Table 173. Cell Projects Ltd. Business Overview
    Table 174. Cell Projects Ltd. Saliva-based ScreeningProduct
    Table 175. Cell Projects Ltd. Revenue in Saliva-based Screening Business (2017-2022) & (US$ Million)
    Table 176. Cell Projects Ltd. Recent Development
    Table 177. Research Programs/Design for This Report
    Table 178. Key Data Information from Secondary Sources
    Table 179. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Saliva-based Screening Market Share by Type: 2021 VS 2028
    Figure 2. Direct Sample to PCR Features
    Figure 3. RT-qPCR Features
    Figure 4. Lateral Flow Assays Features
    Figure 5. Global Saliva-based Screening Market Share by Application in 2021 & 2028
    Figure 6. Diagnostic Laboratories Case Studies
    Figure 7. Hospitals & Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Saliva-based Screening Report Years Considered
    Figure 10. Global Saliva-based Screening Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Saliva-based Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Saliva-based Screening Market Share by Region: 2021 VS 2028
    Figure 13. Global Saliva-based Screening Market Share by Players in 2021
    Figure 14. Global Top Saliva-based Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saliva-based Screening as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Saliva-based Screening Revenue in 2021
    Figure 16. North America Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Saliva-based Screening Market Share by Country (2017-2028)
    Figure 18. United States Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Saliva-based Screening Market Share by Country (2017-2028)
    Figure 22. Germany Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Saliva-based Screening Market Share by Region (2017-2028)
    Figure 30. China Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Saliva-based Screening Market Share by Country (2017-2028)
    Figure 38. Mexico Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Saliva-based Screening Market Share by Country (2017-2028)
    Figure 42. Turkey Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Saliva-based Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Thermo Fisher scientific Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 45. Qiagen Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 46. Hologic Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 47. Takara Bio Inc Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 48. Arcis Biotechnology Limited Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 49. GeneProof Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 50. Abacus ALS Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 51. Chai Inc. Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 52. Kolplast Group Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 53. Lucence Health INc Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 54. Vitagene Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 55. Therma Bright Inc Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 56. ACON Laboratories, Inc Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 57. TODA PHARMA Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 58. Norgen Biotek Corp. Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 59. Assure Tech. (Hangzhou) Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 60. Beijing Hotgen Biotech Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 61. Nantong Diagnos Biotechnology Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 62. NeuMoDx Molecular, Inc. Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 63. KYODO INTERNATIONAL INC. Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 64. Canvax Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 65. Zymo Research Corporation. Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 66. Salimetrics Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 67. NEST Scientific USA Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 68. Miraclean Technology Co. Ltd Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 69. Mawi DNA Technologies Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 70. Cell Projects Ltd. Revenue Growth Rate in Saliva-based Screening Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher scientific
Qiagen
Hologic
Takara Bio Inc
Arcis Biotechnology Limited
GeneProof
Abacus ALS
Chai Inc.
Kolplast Group
Lucence Health INc
Vitagene
Therma Bright Inc
ACON Laboratories, Inc
TODA PHARMA
Norgen Biotek Corp.
Assure Tech. (Hangzhou) Co., Ltd
Beijing Hotgen Biotech Co., Ltd
Nantong Diagnos Biotechnology Co., Ltd
NeuMoDx Molecular, Inc.
KYODO INTERNATIONAL INC.
Canvax
Zymo Research Corporation.
Salimetrics
NEST Scientific USA
Miraclean Technology Co. Ltd
Mawi DNA Technologies
Cell Projects Ltd.
Frequently Asked Questions
Saliva-based Screening report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Saliva-based Screening report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Saliva-based Screening report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports